Main menu

Targeted nanopore sequencing using hybridisation probes reveals immune escape polymorphisms in malaria vaccine candidates


MALARIA

  • Caused by eukaryotic parasites (Plasmodium spp.)
  • Transmitted by anopheline mosquitoes
  • Major cause, and effect of poverty worldwide
  • Increasing resistance to interventions

MALARIA VACCINE DEVELOPMENT

  • Only one candidate has passed Phase 2 trials (RTS,S based on Circumsporozoite Protein, CSP)
  • Partial and short-lived efficacy in infants after 4 doses
  • Evidence of immune escape

PROBLEM:

  • Diverse antigens
  • Immune escape
  • Which polymorphisms?

SOLUTION:

  • Discover polymorphisms associated with immune escape
  • Targeted sequencing using Nanopore
  • Samples from longitudinal cohorts from Papua New Guinea

Download the PDF

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

知识产权 Cookie 政策 企业报告 隐私政策 条件条款 前瞻性陈述

关于 Oxford Nanopore

联系我们 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag